In this study, benzylpiperidine,
the active group of donepezil
(DNP), was connected with the neurotransmitter phenylethylamine by
square amide, in which the fat chain of phenylethylamine was reduced
and the benzene rings were substituted. A series of multifunctional
hybrid compounds, including DNP–aniline hybrids (1–8), DNP–benzylamine hybrids (9–14), and
DNP–phenylethylamine hybrids (15–21) were
obtained and their cholinesterase inhibitory activity and neuroprotection
of the SH-SY5Y cell line were determined. Results showed that compound 3 exhibited excellent acetylcholinesterase inhibitory activity
with an IC50 value of 4.4 μM, higher than that of
positive control DNP and significant neuroprotective effects against
H2O2-induced oxidative damage in SH-SY5Y cells
with 80.11% viability rate at 12.5 μM, much higher than that
of the model group (viability rate = 53.1%). The mechanism of action
of compound 3 was elucidated by molecular docking, reactive
oxygen species (ROS), and immunofluorescence analysis. The results
suggest that compound 3 could be further explored as
a lead compound for the treatment of Alzheimer’s disease. In
addition, molecular docking research indicated that the square amide
group formed strong interactions with the target protein. Based on
the above analysis, we believe that square amide could be an interesting
construction unit in anti-AD agents.